Chari, A. Vogl, D.T. Gavriatopoulou, M. Nooka, A.K. Yee, A.J. Huff, C.A. Moreau, P. Dingli, D. Cole, C. Lonial, S. Dimopoulos, M. Stewart, A.K. Richter, J. Vij, R. Tuchman, S. Raab, M.S. Weisel, K.C. Delforge, M. Cornell, R.F. Kaminetzky, D. Hoffman, J.E. Costa, L.J. Parker, T.L. Levy, M. Schreder, M. Meuleman, N. Frenzel, L. Mohty, M. Choquet, S. Schiller, G. Comenzo, R.L. Engelhardt, M. Illmer, T. Vlummens, P. Doyen, C. Facon, T. Karlin, L. Perrot, A. Podar, K. Kauffman, M.G. Shacham, S. Li, L. Tang, S. Picklesimer, C. Saint-Martin, J.-R. Crochiere, M. Chang, H. Parekh, S. Landesman, Y. Shah, J. Richardson, P.G. Jagannath, S., Oral selinexor-dexamethasone for triple-class refractory multiple myeloma, The New England journal of medicine, (381), 727-738, 2019, Massachussetts Medical Society,